Paul Williams - Concepedia

Author

Paul Williams

Also Known As

Keja Taylor, Leanne Sherris, P Coe, P D Williams, P Williams, P. D. WILLIAMS, P. D. Williams, P. Douglas Williams, P.D. Williams, PAUL WILLIAMS

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

PAREXEL International (United Kingdom)United States Military Academy University of Southampton University College London Mayo Clinic in Arizona

About

Paul Williams is an author at PAREXEL International (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	12	284
2	Natural Sciences	4	4	126
3	Public Health	4	4	116
4	Engineering	1	1	54
5	Health Sciences	1	1	31

Paul Williams

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Renal Calcifications: A Complication of Long-Term Furosemide Therapy in Preterm Infants Karen G. Hufnagle, Shadid N. Khan, Duna Penn, PEDIATRICS	1982	274
Synthesis and structure of Cp2Cp12Mo4S4 cubane clusters: an affirmation of the Dahl binding model Paul Williams, M. David Curtis Inorganic Chemistry EngineeringChemical AnalysisBiomolecular Structure PredictionMolecular BiologyOrganic Chemistry	1986	54
L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor Douglas J. Pettibone, Bradley V. Clineschmidt, Maribeth T. Guidotti, Drug Development Research Reproductive HealthPotential UseGynecologyPreterm Birth PreventionPharmacotherapy	1993	43
Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide Mark G. Bock, Robert M. DiPardo, Paul Williams, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDrug TargetBioorganic ChemistryBiochemistry	1990	39
The Cost Effectiveness of Stratified Care in the Management of Migraine Paul Williams, Andrew Dowson, Alan M. Rapoport, PharmacoEconomics Cluster HeadachePrimary CareHealthcare ValueHealth PolicyHealth Economics	2001	39
Use of the Sustained Pain-Free Plus No Adverse Events Endpoint in Clinical Trials of Triptans in Acute Migraine David W. Dodick, Giorgio Sandrini, Paul Williams CNS Drugs Cluster HeadacheHealth SciencesPain MedicineClinical TrialsPain Management	2007	31
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications Roger Freidinger, Paul Williams, Roger D. Tung, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical Chemistry	1990	23
Barriers to the effective management of bipolar disorder: a survey of psychiatrists based in the UK and USA KN Roy Chengappa, Paul Williams Bipolar Disorders	2005	23

Page 1